# PSMA Imaging of Localized Prostate Cancer

> **NCT03675451** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 20 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 89ZR-DF-IAB2M
- **DRUG:** 68Ga-PSMA-HBED-CC

## Key facts

- **NCT ID:** NCT03675451
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-08
- **Primary completion:** 2018-06-27
- **Final completion:** 2018-06-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675451, "PSMA Imaging of Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03675451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*